Tryptophol (CED0008521)

Record Information
Version1.0
Creation Date2016-05-25 23:36:42 UTC
Update Date2026-04-02 23:43:44 UTC
Accession NumberCHEM027266
Identification
Common NameTryptophol
ClassSmall Molecule
Description
Tryptophol is an organic compound with the formula C10H11NO and an average molecular weight of 161.20 g/mol. Tryptophol belongs to the indoles, a subclass of indoles and derivatives within the organic compounds. This substance is found in or released from five recorded sources. These include food, food processing, and cookware, specifically within fermentation processes for beer, food preservation, and the preparation of wine or sparkling wine. Additionally, it is associated with electrical and electronic equipment, including electrodes and conductors or conductive bodies characterised by the conductive materials.
Contaminant TypeNot Available
Chemical Structure
Synonyms
ValueSource
1H-Indole-3-ethanolChEBI
1H-Indolyl-3-ethanolChEBI
2-(indol-3-yl)EthanolChEBI
3-(2-Hydroxyethyl)indoleChEBI
Indole-3-ethanolChEBI
TryptophanolChEBI
2-(1H-indol-3-yl)EthanolHMDB
2-(3-Indolyl)ethanolHMDB
2-(3-IndolylethanolHMDB
3-(b-Hydroxyethyl)indoleHMDB
3-(beta-Hydroxyethyl)indoleHMDB
3-IndoleethanolHMDB
3-IndolylethanolHMDB
b-(3-Indole)ethanolHMDB
beta-(3-Indole)ethanolHMDB
beta-indol-3-YlethanolHMDB
DL-TryptophanolHMDB
IEAHMDB
Indole ethanolHMDB
IndoleethanolHMDB
TryptopholHMDB, KEGG
3-(2-Hydroxyethyl)-1H-indoleHMDB
3-(β-Hydroxyethyl)indoleHMDB
3-Indole ethanolHMDB
β-(3-Indole)ethanolHMDB
Chemical FormulaC10H11NO
Average Molecular Mass161.200 g/mol
Monoisotopic Mass161.084 g/mol
CAS Registry Number526-55-6
IUPAC Name2-(1H-indol-3-yl)ethan-1-ol
Traditional Nametryptophol
SMILESOCCC1=CNC2=CC=CC=C12
InChI IdentifierInChI=1S/C10H11NO/c12-6-5-8-7-11-10-4-2-1-3-9(8)10/h1-4,7,11-12H,5-6H2
InChI KeyMBBOMCVGYCRMEA-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as 3-alkylindoles. 3-Alkylindoles are compounds containing an indole moiety that carries an alkyl chain at the 3-position.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassIndoles and derivatives
Sub ClassIndoles
Direct Parent3-alkylindoles
Alternative Parents
Substituents
  • 3-alkylindole
  • Benzenoid
  • Substituted pyrrole
  • Heteroaromatic compound
  • Pyrrole
  • Azacycle
  • Organic nitrogen compound
  • Organic oxygen compound
  • Organopnictogen compound
  • Hydrocarbon derivative
  • Primary alcohol
  • Organooxygen compound
  • Organonitrogen compound
  • Alcohol
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted Properties
PropertyValueSource
Water Solubility1.61 g/LALOGPS
logP1.82ALOGPS
logP1.59ChemAxon
logS-2ALOGPS
pKa (Strongest Acidic)15.8ChemAxon
pKa (Strongest Basic)-2.4ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count1ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area36.02 ŲChemAxon
Rotatable Bond Count2ChemAxon
Refractivity48.72 m³·mol⁻¹ChemAxon
Polarizability17.88 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyDeposition DateView
GC-MSGC-MS Spectrumsplash10-0udi-1591000000-5b173cc0ac0dc2b874a9Not AvailableView Spectrum
GC-MSGC-MS Spectrumsplash10-0udi-1591000000-5b173cc0ac0dc2b874a9Not AvailableView Spectrum
GC-MSGC-MS Spectrumsplash10-0udi-0490000000-15708d306e1f75b1e76fNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS Spectrumsplash10-001i-0900000000-d2769447ff27a79be367Not AvailableView Spectrum
Predicted GC-MSPredicted GC-MS Spectrumsplash10-00yi-5690000000-765b6a566d2067c199b0Not AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-01ox-0900000000-5fb5f5b5efe809cbe9adNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00kf-0900000000-44158c348db109504af4Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014l-6900000000-48b709f034a27e74e73fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03di-0900000000-593c6fbb6f64e16e7f05Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03e9-0900000000-54f7b6548b8a00c91c3fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-003u-0900000000-fb2793cd76eefaaf45c5Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-016r-0900000000-a97ae0f4c1633b83c415Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-0900000000-d00c24bc728f46156c60Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03di-0900000000-593c6fbb6f64e16e7f05Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03e9-0900000000-54f7b6548b8a00c91c3fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-003u-0900000000-fb2793cd76eefaaf45c5Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-016r-0900000000-78c3b34c10c43b6a9317Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-0900000000-d00c24bc728f46156c60Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03di-0900000000-d41cd8e81a55b3e00538Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0006-0900000000-5927d4ac720f209af38dNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00kf-5900000000-4bc97e2ed06c230bbbdeNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0006-0900000000-4807fdc919bf8c468f72Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0006-0900000000-63222dc5b6f22cd7cc13Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00kf-9800000000-314e270d78e7a9ec16a9Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0006-0900000000-3f8e0d1410267c0ad66eNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03di-0900000000-aeba8d28d8681fb1473dNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03di-0900000000-b46601ffc736985fcdf8Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-2900000000-3e7e36fd8027ab6c9e96Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-003u-0900000000-2ba4c5a87b74cfd62e02Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-01ox-0900000000-ae84153e5d93042b79c8Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0006-0900000000-b04d1b793a892b605239Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-014l-1900000000-eceb6c67d77a5dddf240Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-03di-0900000000-bfeeeabc14ffd14b537eNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-01q9-0900000000-e45fe37e44b99ede037eNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-014l-2900000000-84aa43c0f5ccfd6511bbNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-03di-0900000000-672a79c8743e20900e34Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-00l6-0900000000-47ecb7b7b36baaed0f10Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-00pi-9700000000-c7a447853b11d5a58af9Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-03di-0900000000-a7434f65d1c13eed1a0aNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0arr-0900000000-627d1b220321d3d96a46Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-014i-0900000000-b8a4cc26ae8700254f45Not AvailableView Spectrum
MSMS Spectrumsplash10-001i-2900000000-20fec68981d54c2e7002Not AvailableView Spectrum
Toxicity Profile
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Toxicity Values
Toxicity ValueUnitValue RangeOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalReference
1170.0Log mg/kg[660:2100]RatLD50oralpredictedNot Available
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
511Conductors Or Conductive Bodies Characterised By The Conductive MaterialsElectrical & Electronic EquipmentNot Available
519ElectrodesElectrical & Electronic EquipmentNot Available
544Fermentation Processes For BeerFood, food processing & cookwareNot Available
545Food PreservationFood, food processing & cookwareNot Available
549Preparation Of Wine Or Sparkling WineFood, food processing & cookwareNot Available
580Manufacture Preparation Of Tobacco ProductsIndustrial manufacturing & chemical processingNot Available
606Plant Growth RegulatorsAgriculture & land managementNot Available
612Body Washing Or Cleaning ImplementsPersonal care & cosmeticsNot Available
614Essential Oils Or PerfumesPersonal care & cosmeticsNot Available
642FootwearTextiles, leather & furnishingsNot Available
650Purses Luggage Hand BagsTextiles, leather & furnishingsNot Available
Pathways
0 pathways

No pathways found

No metabolic pathways have been associated with this synthetic chemical

Targets
StructureProteinUniProt IDOrganismRelationshipDetails
5-hydroxytryptamine receptor 2A structureClick to view 3D structure5-hydroxytryptamine receptor 2AP28223HumansPredicted (SEA)12.7673
5-hydroxytryptamine receptor 1A structureClick to view 3D structure5-hydroxytryptamine receptor 1AP08908HumansPredicted (SEA)24.6782
Click to view 3D structureSodium-dependent serotonin transporterP31652Rattus norvegicusPredicted (SEA)9.49761
5-hydroxytryptamine receptor 2C structureClick to view 3D structure5-hydroxytryptamine receptor 2CP28335HumansPredicted (SEA)15.3363
Click to view 3D structureNorepinephrine transporterQ9WTR4Rattus norvegicusPredicted (SEA)4.35956
5-hydroxytryptamine receptor 6 structureClick to view 3D structure5-hydroxytryptamine receptor 6P50406HumansPredicted (SEA)8.71911
Click to view 3D structureSodium-dependent dopamine transporterP23977Rattus norvegicusPredicted (SEA)8.01847
Click to view 3D structure5-hydroxytryptamine receptor 2BP30994Rattus norvegicusPredicted (SEA)0.856341
Click to view 3D structure5-hydroxytryptamine receptor 1AP19327Rattus norvegicusPredicted (SEA)26.6244
5-hydroxytryptamine receptor 7 structureClick to view 3D structure5-hydroxytryptamine receptor 7P34969HumansPredicted (SEA)18.9174
5-hydroxytryptamine receptor 1B structureClick to view 3D structure5-hydroxytryptamine receptor 1BP28222HumansPredicted (SEA)9.809
5-hydroxytryptamine receptor 2B structureClick to view 3D structure5-hydroxytryptamine receptor 2BP41595HumansPredicted (SEA)19.6959
5-hydroxytryptamine receptor 2A structureClick to view 3D structure5-hydroxytryptamine receptor 2AP14842Rattus norvegicusPredicted (SEA)23.4326
Sodium-dependent serotonin transporter structureClick to view 3D structureSodium-dependent serotonin transporterP31645HumansPredicted (SEA)28.2593
5-hydroxytryptamine receptor 1D structureClick to view 3D structure5-hydroxytryptamine receptor 1DP28221HumansPredicted (SEA)14.6357
D(2) dopamine receptor structureClick to view 3D structureD(2) dopamine receptorP14416HumansPredicted (SEA)89.9937
Myeloperoxidase structureClick to view 3D structureMyeloperoxidaseP05164HumansPredicted (SEA)1.47914
5-hydroxytryptamine receptor 5A structureClick to view 3D structure5-hydroxytryptamine receptor 5AP47898HumansPredicted (SEA)8.32987
D(3) dopamine receptor structureClick to view 3D structureD(3) dopamine receptorP35462HumansPredicted (SEA)81.4303
Alpha-2A adrenergic receptor structureClick to view 3D structureAlpha-2A adrenergic receptorP08913HumansPredicted (SEA)26.2352
Alpha-2B adrenergic receptor structureClick to view 3D structureAlpha-2B adrenergic receptorP18089HumansPredicted (SEA)18.5281
Alpha-1A adrenergic receptor structureClick to view 3D structureAlpha-1A adrenergic receptorP35348HumansPredicted (SEA)38.6911
Histamine H1 receptor structureClick to view 3D structureHistamine H1 receptorP35367HumansPredicted (SEA)42.1943
Click to view 3D structure5-hydroxytryptamine receptor 1BP28564Rattus norvegicusPredicted (SEA)17.3604
Click to view 3D structureAlpha-1D adrenergic receptorP25100HumansPredicted (SEA)27.5586
Concentrations
Not Available
External Links
DrugBank IDNot Available
HMDB IDHMDB0003447
FooDB IDFDB010973
Phenol Explorer IDNot Available
KNApSAcK IDC00000114
BiGG IDNot Available
BioCyc IDCPD-341
METLIN ID6932
PDB IDNot Available
Wikipedia LinkTryptophol
Chemspider ID10235
ChEBI ID17890
PubChem Compound ID10685
Kegg Compound IDC00955
YMDB IDYMDB00577
ECMDB IDM2MDB005506
References
Synthesis ReferenceNot Available
MSDSNot Available
General References
1. https://www.ncbi.nlm.nih.gov/pubmed/?term=10856636
2. https://www.ncbi.nlm.nih.gov/pubmed/?term=12499363
3. https://www.ncbi.nlm.nih.gov/pubmed/?term=16664264
4. https://www.ncbi.nlm.nih.gov/pubmed/?term=19842066
5. https://www.ncbi.nlm.nih.gov/pubmed/?term=23413824
6. https://www.ncbi.nlm.nih.gov/pubmed/?term=24032669
7. https://www.ncbi.nlm.nih.gov/pubmed/?term=24253838
8. Snyder, H. R.; Pilgrim, Frederick J. Preparation of 3-indoleacetic acid; new synthesis of tryptophol. Journal of the American Chemical Society (1948), 70 3770-1.
9. Snyder, H. R.; Pilgrim, Frederick J. Preparation of 3-indoleacetic acid; new synthesis of tryptophol. Journal of the American Chemical Society (1948), 70 3770-1.
10. Roager HM, Licht TR: Microbial tryptophan catabolites in health and disease. Nat Commun. 2018 Aug 17;9(1):3294. doi: 10.1038/s41467-018-05470-4.
11. Schirmer M, Smeekens SP, Vlamakis H, Jaeger M, Oosting M, Franzosa EA, Ter Horst R, Jansen T, Jacobs L, Bonder MJ, Kurilshikov A, Fu J, Joosten LAB, Zhernakova A, Huttenhower C, Wijmenga C, Netea MG, Xavier RJ: Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity. Cell. 2016 Nov 3;167(4):1125-1136.e8. doi: 10.1016/j.cell.2016.10.020.
12. Cornford EM, Crane PD, Braun LD, Bocash WD, Nyerges AM, Oldendorf WH: Reduction in brain glucose utilization rate after tryptophol (3-indole ethanol) treatment. J Neurochem. 1981 May;36(5):1758-65.